|
Pharmacology
Citations 21-30 of 165 total displayed.
|
Past content
(since Dec 2002):
|
- CLINICAL
Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis
- Takeo Sato, Shigeko Inokuma, Akira Sagawa, Takemasa Matsuda, Tamiko Takemura, Takeshi Otsuka, Yukihiko Saeki, Tsutomu Takeuchi, and Tetsuji Sawada on behalf of the Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology
Rheumatology 2009; 48: 1265-1268.
[Abstract]
[Full Text]
- CLINICAL
Validity of physician-reported hospitalized infections in a US arthritis registry
- Jeffrey R. Curtis, Nivedita M. Patkar, Archana Jain, Jeffrey Greenberg, and Daniel H. Solomon
Rheumatology 2009; 48: 1269-1272.
[Abstract]
[Full Text]
- CLINICAL
Usefulness of initial histological features for stratifying Sjögren's syndrome responders to mizoribine therapy
- Shingo Nakayamada, Takashi Fujimoto, Akitaka Nonomura, Kazuyoshi Saito, Shinobu Nakamura, and Yoshiya Tanaka
Rheumatology 2009; 48: 1279-1282.
[Abstract]
[Full Text]
- CLINICAL
The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study
- Aslam Anis, Wei Zhang, Paul Emery, Huiying Sun, Amitabh Singh, Bruce Freundlich, and Reiko Sato
Rheumatology 2009; 48: 1283-1289.
[Abstract]
[Full Text]
- CLINICAL
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity
- Kimme L. Hyrich, Chris Deighton, Kath D. Watson, BSRBR Control Centre Consortium, Deborah P. M. Symmons, and Mark Lunt on behalf of the British Society for Rheumatology Biologics Register
Rheumatology 2009; 48: 1323-1327.
[Abstract]
[Full Text]
- CASE REPORTS
Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement
- Isabelle Marie, Laure Lahaxe, Séverine Josse, and Hervé Levesque
Rheumatology 2009; 48: 1328-1329.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Screening for Mycobacterium tuberculosis prior to anti-TNF therapy—an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence
- Batsi Chikura, Veena Sadananda, and Muniba Usman-Saeed
Rheumatology 2009; 48: 1331-1332.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Screening for Mycobacterium tuberculosis prior to anti-TNF therapy—an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence: reply
- John D. Pradeep, Gavin P. R. Clunie, Karl Gaffney, Nicholas J. Innes, Alan Brooksby, Pamela Bradley, and Atul Gulati
Rheumatology 2009; 48: 1332-a.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials
- Brian J. Sweetman
Rheumatology 2009; 48: 1332-1333.
[Extract]
[Full Text]
- MATTERS ARISING
Comment on: Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials: reply
- Luciana A. C. Machado
Rheumatology 2009; 48: 1333.
[Extract]
[Full Text]
|
|
